NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported that its fourth-quarter 2012 revenues grew 7 percent, driven by strong sales for its SAFC business unit.

The St. Louis-based chemicals and research products firm reported total revenues of $655 million for the three months ended Dec. 31, compared to $610 million for the fourth quarter of 2011. It fell short of the consensus Wall Street estimate for revenues of $659.6 million. On an organic basis, the firm's revenues grew 3 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.